The science is in: Aspirin for CVD primary prevention is out

Nevertheless, the practice is still widespread globally despite being controversial
Aspirin

Aspirin for primary prevention of cardiovascular events is ‘out’ in the wake of a landmark review, a leading researcher says.

Professor Mark Nelson, chair of general practice at the University of Tasmania, says the science is now “pretty much settled”.